Microbot Medical Inc expected to post a loss of 51 cents a share - Earnings Preview
11/11/2022 11:58
* Microbot Medical Inc MBOT.OQ MBOT.O is expected
to report
results on November 14 (estimated).
*
* Refinitiv's mean analyst estimate for Microbot Medical
Inc is
for a loss of 51 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Microbot
Medical
Inc is $20, above its last closing price of $3.53.
This summary was machine generated November 11 at 11:58 GMT.
All figures in US dollars unless otherwise stated
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones